The best evidence available should guide practice.
-
-
Like, obviously in absence of all evidence it's reasonable to try whatever you think is best, but the absence of evidence at a certain point is an active choice because often people would rather use treatments than trial them (Gilead/remdesivir is a good example)
-
I agree reasonably strongly for drugs early in patent, but for repurposed drugs harder to apply.
End of conversation
New conversation -
-
-
And how do you think we could have got our first small trial done that fast, let alone a larger one? Easier said than done. You might think with so many people sick at once, it would be easy to run a trial during a pandemic, but it’s not: Lots of barriers.
-
I think the "shit together" is the clause of barriers he was referring to.
End of conversation
New conversation -
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.